De Novo Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Professionals
  • 3

Professionals

  • Investments
  • 129

  • Portfolio
  • 1

  • Exits
  • 64

Exits

De Novo Ventures General Information

Company Description

Founded in 2000, De Novo Ventures was a venture capital firm based in Saratoga, California, The firm preferred to invest in early-stage and later-stage firms in the medical devices and biotechnology sectors.

Business Details

Year Founded
2000
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Corporate Office
  • Post Office Box 2160
  • Saratoga, CA 95070
  • United States

De Novo Ventures Investments (129)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Milo (Electronic Equipment and Instruments) 16-Jun-2021 Early Stage VC 0000 Electronic Equipment and Instruments Generating Revenue
Pulmonx 05-May-2020 00000 00000 0000 Other Devices and Supplies Generating Revenue/Not Profitable 0000000 0000000
Benvenue Medical 06-Jan-2016 00000 00000 0000 Therapeutic Devices Generating Revenue 0000000 0000000
Allakos 24-Sep-2014 00000 00000 0000 Drug Delivery Generating Revenue
Benvenue Medical 18-Jun-2014 00000 00000 0000 Therapeutic Devices Generating Revenue 0000000 0000000
Spinal Kinetics 02-Jun-2014 00000 00000 0000 Surgical Devices Generating Revenue 0000000 0000000
EndoGastric Solutions 07-May-2014 00000 00000 000.00 Surgical Devices Generating Revenue 000000 0000000 00.0
SensorCath 10-Jan-2014 00000 00000 00.000 Other Commercial Services Out of Business
Otonomy 17-Dec-2013 Later Stage VC 000.00 Drug Discovery Generating Revenue
Pacira CryoTech 12-Sep-2013 Later Stage VC 0000 Therapeutic Devices Profitable 0000000 0000000
You’re viewing 10 of 129 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

De Novo Ventures Exits (64)

Company Name Exit Date Exit Type Exit Size
BAROnova 24-Jun-2022 Secondary Transaction - Private
EndoGastric Solutions 24-Jun-2022 000000000 00000000
EBR Systems 01-Oct-2021 000 000.00
Empirical Spine 01-Oct-2021 000000000 00000000
SensorCath 27-May-2021 000 00 00000000
Viracta Therapeutics 24-Feb-2021 0000000 000000
ProMed 01-Jan-2021 000000000 00000000
Benvenue Medical 16-Dec-2020 0000000000
Pulmonx 01-Oct-2020 IPO 00000
Avedro 21-Nov-2019 Merger/Acquisition 00000
You’re viewing 10 of 64 exits. Get the full list »

De Novo Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore De Novo Ventures‘s full profile, request access.

Request a free trial

De Novo Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

De Novo Ventures Management, Team & Partners (9)

Name Title Deals Funds Boards Office
Richard Ferrari Co-Founder, Executive Chairman & Managing Director 00 0 00 Saratoga, CA
You’re viewing 1 of 9 team members. Get the full list »

De Novo Ventures Co-Investors (16)

Name With Exits Lead Partner Series Industry
Boston Scientific 1 0 Series chart Industry bar
HealthCap 0 0 Series chart Industry bar
Kleiner Perkins 0 0 Series chart Industry bar
Latterell Venture Partners 0 0 Series chart Industry bar
MedVenture Associates 0 0 Series chart Industry bar
You’re viewing 5 of 16 co-investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »